jRCT2080223943已完成3 期
An Open-label Study to Assess the Effect of JTT-751 as Iron Replacement Therapy in Patients with Iron Deficiency Anemia
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 70
- 试验地点
- 1
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Multi-center, Uncontrolled, Open-label study
- 主要目的
- Treatment Purpose
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Iron deficiency anemia
- •Hemoglobin level of >= 8.0 g/dL and < 11.0 g/dL
排除标准
- •Anemia caused by other than iron deficiency
- •Serum phosphate < 2.5 mg/dL or >= 4.5 mg/dL
- •Patients scheduled surgical treatment for gynecological diseases with hypermenorrhea during participation
结局指标
主要结局
-
efficacy Changes in serum ferritin level
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
A Study on Iron deficiency anaemia classified and Managed with HomoeopathyCTRI/2024/07/071486DEPARTMENT OF ORGANON OF ORGANON OF MEDICINE AND HOMOEOPATHY PHILOSOPHY
尚未招募
Unknown
Study on the treatment of Iron Deficiency Anemia In Children with the help of Homoeopathic Medicines based on physical and mental character of an individualCTRI/2023/07/054630WHITE MEMORIAL HOMOEO MEDICAL COLLEGE AND HOSPITA
招募中
2 期
A clinical study on Chitramutti nei in patients with low haemoglobin levelCTRI/2017/08/009553Govt siddha medical college
进行中（未招募）
不适用
Pilot Study: Iron-chelating treatment in patients with Neurodegeneration with Brain Iron Accumulation (NBIA). - NDEUCTR2008-005206-39-ITAZIENDA OSPEDALIERA OSPEDALI GALLIERA
进行中（未招募）
1 期
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT